跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版

Series Editor

Luis Sobrevia

PLS

Professor Luis Sobrevia

Director of the Cellular and Molecular Physiology Laboratory (CMPL)

Faculty of Medicine, Pontificia Universidad Católica de Chile

電子郵件 Professor Luis Sobrevia

Luis Sobrevia, Chilean, holds a BSc in Biology and Natural Sciences from the Universidad del Bío-Bío and MSc in Physiological Sciences from the Universidad de Concepción (Chile), and a PhD in Physiology and Medical Sciences, with postdoctoral training in vascular pathophysiology at King’s College London from the University of London (UK). He holds a Diploma in Teaching from the Pontificia Universidad Católica de Chile (PUC). He is a Fellow of The Physiological Society (UK) (FTPS), a Fellow of the Academy of Physiology of the International Union of Physiological Sciences (FIUPS), a Fellow of the Royal Society of Medicine (FRSM), member of the Academy of Sciences of Latin-America (ACAL), Professor of Molecular Physiology and Medicine at the Faculty of Medicine at PUC, Honorary Professor at University of Queensland (Australia), Universidad de Sevilla (Spain), and São Paulo State University (UNESP, Brazil), and Collaborator Professor at Faculty of Medicine, UNESP (Brazil).

Dr. Sobrevia is the Director of the Cellular and Molecular Physiology Laboratory (CMPL) at PUC (Chile) and CMPL at UNESP (Brazil). Editor-in-Chief of Physiological Mini Reviews, co-Editor-in-Chief of Current Vascular Pharmacology, Executive Editor and member of the editorial board of several scientific/medical journals, IUPS Representative to Americas, member of the Cardiovascular and Respiratory Council Commission of IUPS, co-Chair of the Liaison Committee of the Regional Focal Point for Latin America and the Caribbean (RFP LAC) of the International Science Council (ISC). His research focus is altered fetoplacental vascular function in diseases of pregnancy, including gestational diabesity, gestational diabetes mellitus, preeclampsia, and maternal obesity.